Ying Ming Wang
Direktor/Vorstandsmitglied bei NOVOPROTEIN SCIENTIFIC INC.
Profil
Ying Ming Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
Prior to this, Mr. Wang was the Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
from 2009 to the present.
Mr. Wang graduated from Fudan University in 2014.
Aktive Positionen von Ying Ming Wang
Unternehmen | Position | Beginn |
---|---|---|
NOVOPROTEIN SCIENTIFIC INC. | Direktor/Vorstandsmitglied | 01.02.2019 |
Novoprotein Scientific (Shanghai), Inc.
Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Direktor/Vorstandsmitglied | 12.08.2020 |
Ausbildung von Ying Ming Wang
Fudan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
Novoprotein Scientific (Shanghai), Inc.
Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |